|
Title |
Impact of COVID-19 pandemic on viral
keratitis |
|
Authors |
Ankita Baghel1,*, Aditi Mishra1, Sanskriti Ukey1, Pankaj Choudhary2 & Sachin Parmar3
|
|
Affiliation |
1Department of Ophthalmology, NandKumar Singh Chauhan Medical College, Khandwa, Madhya Pradesh, India; 2Department of Ophthalmology, Shyam Shah Medical College, Rewa, Madhya Pradesh, India; 3Department of Community Medicine, V.K.S. Government Medical College, Neemuch, Madhya Pradesh, India; *Corresponding author
|
|
|
Ankita Baghel - E-mail:
ankibaghel24@gmail.com Sachin Parmar - E-mail: dr.sachinparmar@gmail.com
|
|
Article Type |
Research Article
|
|
Date |
Received April 1, 2026; Revised April 30, 2026; Accepted April 30,
2026, Published April 30, 2026 |
|
Abstract |
COVID-19 has altered the epidemiology and clinical course of viral keratitis, with increasing evidence of herpesvirus reactivation after infection or vaccination. HSV keratitis remains most common in younger-to-middle-aged men, while HZO predominates in older adults and around one-fourth of HZO patients report current or prior COVID-19. HSV cases frequently recur and complications such as corneal opacity and neuropathic pain can cause vision outcomes ranging from normal to severe loss. Large recent studies suggest vaccination is associated with higher risk of new-onset and relapsing herpesviral keratitis, supporting antiviral prophylaxis for high-risk patients. Thus, screening around COVID-19 illness or vaccination and early, structured antiviral treatment reduces long-term visual impairment. |
|
Keywords |
Keratitis, herpetic; COVID-19; vaccination; reactivation
|
|
Citation |
Baghel et al. Bioinformation 22(4): 2253-2258 (2026)
|
|
Edited by |
P Kangueane
|
|
ISSN |
0973-2063
|
|
Publisher |
|
|
License |
This is an Open Access article which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. This is distributed under the terms of the Creative Commons Attribution License.
|
|
|
|